Journal
CANCER LETTERS
Volume 485, Issue -, Pages 38-44Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2020.04.023
Keywords
Bladder cancer; Non-coding RNAs; Diagnosis
Categories
Funding
- National Natural Science Foundation of China [81672956, 81972390]
- Beijing Science and Technology Project [Z181100003818003]
- Beijing-Tianjin-Hebei Basic Research Cooperation Project [19JCZDJC65800Z]
- Key Clinical Projects of Peking University Third Hospital [BYSY2017001]
Ask authors/readers for more resources
Bladder cancer is the tenth most common cancer worldwide and has been associated with high mortality and morbidity. Although the treatment of bladder cancer is based on well-defined tumor classifications and gradings, patients still experience different clinical response. The heterogeneity of this disease calls for substantial research with more in-depth molecular characterization, with the hope of identifying new diagnostic and treatment options. In recent years, non-coding RNAs (ncRNAs), particularly, microRNAs (miRNAs), long non-coding RNA (lncRNAs), and circular RNAs (circRNAs) were found to be associated with bladder cancer occurrence and development. This review highlights the recent findings concerning ncRNAs and their relevance to the pathogenesis of bladder cancer. This may provide a foundation for developing highly specific diagnostic tools and more robust therapeutic strategies in the future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available